Anne Wojcicki Reclaims Control of 23andMe in $305 Million Deal

In a strategic move, Anne Wojcicki, who co-founded and is a former CEO of 23andMe, has successfully regained dominion over the beleaguered genetic testing firm.

Through her newly formed nonprofit, TTAM Research Institute, Wojcicki outmaneuvered other bidders by offering $305 million to secure almost all of 23andMe's holdings. This acquisition encompasses the company's primary services, including its Personal Genome Service and the associated Research Services, in addition to the telehealth branch, Lemonaid Health.

A Turnaround for 23andMe

The acquisition marks a significant victory for Wojcicki, who had departed from her CEO role when 23andMe filed for bankruptcy in March. Recently, Regeneron had attempted to purchase a considerable portion of 23andMe’s resources, placing a bid of $256 million. However, Wojcicki’s TTAM submitted a higher offer, prompting a reopening of the auction process.

TTAM, which cleverly uses the initial letters of 23andMe, represents Wojcicki's vision to advance the company’s initial mission. Wojcicki expressed her enthusiasm in a statement, highlighting the institute's commitment to enabling people to understand and leverage the information offered by the human genome.

The Rise and Challenges of 23andMe

23andMe revolutionized personal genomics with its home DNA testing kits, providing users with Ancestry and genetic data insights. The company reached a pivotal point in 2021, merging with a special purpose acquisition company and achieving a market valuation close to $6 billion.

Despite its early promise, 23andMe struggled with consistent revenue generation and establishing a sustainable trajectory for its research and drug development divisions. These efforts were further complicated by significant privacy issues that came to light following a data breach affecting almost 7 million users in 2023.

Awaiting Final Approval

The closure of TTAM's acquisition of 23andMe remains contingent upon the nod from the U.S. Bankruptcy Court for the Eastern District of Missouri. The ruling will decide the future steps in Wojcicki's plan to rejuvenate the company's mission and operations.